Polymeric Nanoparticle Associated with Ceftriaxone and Extract of Schinopsis Brasiliensis Engler againstMultiresistant Enterobacteria

dc.contributor.authorOliveira, Maisa Soares de
dc.contributor.authorOshiro-Junior, Joao Augusto
dc.contributor.authorSato, Mariana Rillo [UNESP]
dc.contributor.authorConceicao, Marta Maria
dc.contributor.authorDantas Medeiros, Ana Claudia
dc.contributor.institutionUniv Estadual Paraiba
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniv Fed Paraiba
dc.date.accessioned2020-12-10T17:41:25Z
dc.date.available2020-12-10T17:41:25Z
dc.date.issued2020-08-01
dc.description.abstractBacterial resistance has become an important public health problem. Bacteria have been acquiring mechanisms to resist the action of antimicrobial active pharmaceutical ingredients (API). Based on this, a promising alternative is the use of nanotechnology, since when the systems are presented in nanometric size, there is an increase in the interaction and concentration of the action at the target site improving the activity. Thus, this study aims to develop a polymeric nanoparticle (PN) composed of chitosan and hydroxypropylmethylcellulose, as an innovative strategy for the administration of an association between ceftriaxone and extract ofS. brasiliensis, for the treatment of Enterobacteriaceae. From a Box-Behnken design, nanoparticles were obtained and evaluated using the DLS technique, obtaining the particle size between 440 and 1660 nm, IPD from 0.42 to 0.92, and positive charges. Morphological characteristics of PN by SEM revealed spherical morphology and sizes similar to DLS. Infrared spectroscopy showed no chemical interaction between the components of the formulation. The broth microdilution technique evaluated their antimicrobial activity, and a considerable improvement in the activity of the extract and the API compared to the free compounds was found, reaching an improvement of 133 times in the minimum inhibitory activity CRO.en
dc.description.affiliationUniv Estadual Paraiba, Ctr Ciencias Biol & Saude, Lab Desenvolvimento & Ensaios Medicamentos, R Baraunas 351,Cidade Univ, BR-58429500 Campina Grande, Paraiba, Brazil
dc.description.affiliationUniv Estadual Paulista, Fac Ciencias Farmaceut, Km 1, BR-14800903 Araraquara, SP, Brazil
dc.description.affiliationUniv Fed Paraiba, Ctr Tecnol & Desenvolvimento Reg, Av Escoteiros S-N,Mangabeira 7, BR-58055000 Joao Pessoa, Paraiba, Brazil
dc.description.affiliationUnespUniv Estadual Paulista, Fac Ciencias Farmaceut, Km 1, BR-14800903 Araraquara, SP, Brazil
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipIdCAPES: 001
dc.format.extent18
dc.identifierhttp://dx.doi.org/10.3390/pharmaceutics12080695
dc.identifier.citationPharmaceutics. Basel: Mdpi, v. 12, n. 8, 18 p., 2020.
dc.identifier.doi10.3390/pharmaceutics12080695
dc.identifier.urihttp://hdl.handle.net/11449/195639
dc.identifier.wosWOS:000564055900001
dc.language.isoeng
dc.publisherMdpi
dc.relation.ispartofPharmaceutics
dc.sourceWeb of Science
dc.subjectbacterial resistance
dc.subjectEnterobacteriaceae
dc.subjectchitosan
dc.subjectHPMC
dc.titlePolymeric Nanoparticle Associated with Ceftriaxone and Extract of Schinopsis Brasiliensis Engler againstMultiresistant Enterobacteriaen
dc.typeArtigo
dcterms.rightsHolderMdpi

Arquivos

Coleções